Metalmark Capital Investor
Metalmark Capital is a leading private equity firm established by the principals of Morgan Stanley Capital Partners (MSCP) to manage the
Technology:
Cell_Therapies
Headquarters:
New York, New York, United States
Founded Date:
1986-01-01
Employees Number:
11-50
Number Of Exits:
3
Estimated Revenue:
$1M to $10M
Register and Claim Ownership